111 EBITDA Margin 2018-2025 | YI
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for 111 (YI) over the last 10 years. The current EBITDA margin for 111 as of March 31, 2025 is .
| 111 EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $1.97B | $0.00B | -0.05% |
| 2024-12-31 | $1.97B | 0 | 0.00% |
| 2024-09-30 | $2.06B | $-0.03B | -1.36% |
| 2024-06-30 | $2.05B | $-0.04B | -1.91% |
| 2024-03-31 | $2.06B | $-0.05B | -2.19% |
| 2023-12-31 | $2.11B | $-0.05B | -2.33% |
| 2023-09-30 | $2.09B | $-0.03B | -1.63% |
| 2023-06-30 | $2.05B | $-0.03B | -1.66% |
| 2023-03-31 | $2.03B | $-0.04B | -1.97% |
| 2022-12-31 | $1.96B | $-0.05B | -2.71% |
| 2022-09-30 | $1.96B | $-0.06B | -2.91% |
| 2022-06-30 | $2.01B | $-0.07B | -3.64% |
| 2022-03-31 | $2.02B | $-0.09B | -4.45% |
| 2021-12-31 | $1.95B | $-0.10B | -5.13% |
| 2021-09-30 | $1.84B | $-0.11B | -5.82% |
| 2021-06-30 | $1.67B | $-0.10B | -5.87% |
| 2021-03-31 | $1.43B | $-0.08B | -5.73% |
| 2020-12-31 | $1.26B | $-0.07B | -5.72% |
| 2020-09-30 | $0.99B | $-0.07B | -7.14% |
| 2020-06-30 | $0.80B | $-0.07B | -8.74% |
| 2020-03-31 | $0.69B | $-0.07B | -10.39% |
| 2019-12-31 | $0.57B | $-0.07B | -12.68% |
| 2019-09-30 | $0.45B | $-0.07B | -14.99% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.065B | $1.973B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.023B | 58.55 |
| Doximity (DOCS) | United States | $11.285B | 52.24 |
| Hims & Hers Health (HIMS) | United States | $11.252B | 116.91 |
| Tempus AI (TEM) | United States | $10.318B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.301B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.107B | 64.17 |
| Hinge Health (HNGE) | United States | $3.444B | 0.00 |
| Privia Health (PRVA) | United States | $2.573B | 175.83 |
| Enovis (ENOV) | United States | $2.053B | 11.45 |
| Phreesia (PHR) | United States | $1.706B | 0.00 |
| Schrodinger (SDGR) | United States | $1.593B | 0.00 |
| Azenta (AZTA) | United States | $1.563B | 72.66 |
| 10x Genomics (TXG) | United States | $1.554B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.552B | 0.00 |
| Omnicell (OMCL) | United States | $1.395B | 24.60 |
| Evolent Health (EVH) | United States | $1.318B | 112.30 |
| Claritev (CTEV) | United States | $0.783B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.595B | 0.00 |
| Standard BioTools (LAB) | United States | $0.513B | 0.00 |
| Veradigm (MDRX) | United States | $0.498B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.462B | 0.00 |
| Talkspace (TALK) | United States | $0.460B | 137.50 |
| Outset Medical (OM) | United States | $0.365B | 0.00 |
| TruBridge (TBRG) | United States | $0.345B | 765.33 |
| Health Catalyst (HCAT) | United States | $0.278B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.264B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.250B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.172B | 0.00 |
| American Well (AMWL) | United States | $0.131B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.119B | 0.00 |
| Pulmonx (LUNG) | United States | $0.107B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.102B | 3.90 |
| Zepp Health (ZEPP) | Netherlands | $0.088B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.083B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.076B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Precipio (PRPO) | United States | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |